Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

BUY
$13.31 - $19.86 $128,335 - $191,490
9,642 Added 34.45%
37,629 $747,000
Q4 2022

Feb 07, 2023

SELL
$12.74 - $15.12 $14,893 - $17,675
-1,169 Reduced 4.01%
27,987 $381,000
Q3 2022

Oct 25, 2022

SELL
$12.93 - $17.17 $2,107 - $2,798
-163 Reduced 0.56%
29,156 $404,000
Q2 2022

Aug 08, 2022

BUY
$13.53 - $23.34 $7,441 - $12,837
550 Added 1.91%
29,319 $421,000
Q1 2022

May 06, 2022

SELL
$16.14 - $22.6 $7,553 - $10,576
-468 Reduced 1.6%
28,769 $650,000
Q4 2021

Feb 08, 2022

SELL
$18.64 - $36.77 $8,798 - $17,355
-472 Reduced 1.59%
29,237 $549,000
Q3 2021

Oct 28, 2021

SELL
$32.83 - $43.0 $7,255 - $9,503
-221 Reduced 0.74%
29,709 $975,000
Q2 2021

Jul 27, 2021

SELL
$34.41 - $44.03 $3,337 - $4,270
-97 Reduced 0.32%
29,930 $1.28 Million
Q1 2021

May 03, 2021

SELL
$37.29 - $47.19 $81,702 - $103,393
-2,191 Reduced 6.8%
30,027 $1.15 Million
Q4 2020

Feb 04, 2021

SELL
$34.3 - $44.09 $165,806 - $213,131
-4,834 Reduced 13.05%
32,218 $1.41 Million
Q3 2020

Nov 06, 2020

BUY
$27.86 - $39.35 $255,838 - $361,351
9,183 Added 32.95%
37,052 $1.46 Million
Q2 2020

Aug 04, 2020

SELL
$30.3 - $42.55 $62,630 - $87,950
-2,067 Reduced 6.9%
27,869 $879,000
Q1 2020

Apr 27, 2020

BUY
$30.0 - $54.18 $175,770 - $317,440
5,859 Added 24.33%
29,936 $1.05 Million
Q4 2019

Feb 03, 2020

BUY
$42.29 - $52.2 $3,044 - $3,758
72 Added 0.3%
24,077 $1.17 Million
Q3 2019

Oct 31, 2019

BUY
$42.06 - $51.64 $15,562 - $19,106
370 Added 1.57%
24,005 $1.14 Million
Q2 2019

Aug 09, 2019

SELL
$33.93 - $43.66 $305 - $392
-9 Reduced 0.04%
23,635 $1.02 Million
Q1 2019

May 02, 2019

BUY
$26.74 - $41.32 $632,240 - $976,970
23,644 New
23,644 $914,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.